Related Experiment Video
Updated: Jul 7, 2025

09:33
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.0K
[Environmental pollutants and Alzheimer's disease]
Sheng Li Xue Bao : [Acta Physiologica Sinica]
|December 27, 2023
Summary
Environmental pollutants like heavy metals and pesticides may contribute to Alzheimer's disease (AD) pathogenesis. This review explores the link between environmental toxins and AD, examining neurotoxic mechanisms and epidemiological evidence.
Area of Science:
- Neuroscience
- Environmental Health
- Toxicology
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by cognitive decline.
- Key hypotheses for AD pathogenesis include beta-amyloid plaques, Tau protein phosphorylation, and neuroinflammation.
- Emerging evidence suggests environmental pollutants play a significant role in neurological dysfunction.
Approach:
- This review synthesizes epidemiological data and animal experimental studies connecting environmental pollution to AD.
- It examines the neurotoxic mechanisms of various environmental contaminants.
- The study provides insights into the complex relationship between environmental factors and AD.
Key Points:
- Environmental pollutants such as heavy metals, pesticides, PCBs, microplastics, and air pollutants exhibit neurotoxicity.
- Studies indicate a correlation between exposure to these pollutants and increased risk or progression of AD.
- Understanding the specific mechanisms of pollutant-induced neurotoxicity is crucial for AD research.
Conclusions:
- Environmental pollution is a significant, yet often overlooked, factor in Alzheimer's disease development.
- Further research into the specific pathways and toxins involved can inform preventative strategies for AD.
- This review highlights the need to consider environmental exposures in the context of AD etiology.
Related Concept Videos
Alzheimer's Disease: Overview
491
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
491
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Types of Toxins
1.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.7K
Role of Neurotransmitters in Memory
564
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
564
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Psychoneuroimmunology: Diabetes and Cancer
29
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
29

